Oxaliplatin-Induced Thrombotic Thrombocytopenic Purpura: Case Report and Literature Review
- 1 November 2012
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (31), e312-e314
- https://doi.org/10.1200/jco.2012.42.5082
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Mitomycin–C-Induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: Cumulative Toxicity of an Old Drug in a New EraClinical Colorectal Cancer, 2011
- Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: the role of rituximabTransfusion, 2010
- Thrombotic Microangiopathy and Occult NeoplasiaCardiovascular & Hematological Disorders-Drug Targets, 2010
- Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathiesBest Practice & Research Clinical Haematology, 2009
- Gemcitabine‐associated thrombotic microangiopathyCancer, 2004
- Thrombotic Thrombocytopenic Purpura: Yesterday, Today, TomorrowTherapeutic Apheresis and Dialysis, 2004
- Drug‐induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: A Concise ReviewTherapeutic Apheresis and Dialysis, 2004
- Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving proteaseBest Practice & Research Clinical Haematology, 2001
- Drug-Induced Thrombotic MicroangiopathyDrug Safety, 2001
- Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.Journal of Clinical Oncology, 1989